New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- Mine That Bird Still Flies in Kentucky
- Sisterly Love Scores Doubledogdare Upset
- Speightstown Colt Works Quick Quarter at OBS
- TimeformUS Saturday Stakes Plays
- Indiana Grand Racing & Casino Begins New Era
- Churchill Derby, Oaks Security Plan Released
- Samraat, Uncle Sigh Work at Belmont
- A Case for Full Siblings
- Mike Mitchell to Step Down as Head Trainer
- Oaklawn Posts Double-Digit Handle Gains